Diabetes patients welcome a more convenient, safer, less painful treatment plan
China currently has 114 million diabetic patients, the highest in the world, and still growing. 1. It can easily treat diabetes without the need for needles. This more comfortable medical experience is also becoming a reality.
Beijing Kushur Medical Technology Co., Ltd. (hereinafter referred to as 'Quansul') has designed and manufactured a safe and efficient new needle-free syringe product that enhances the medical experience of diabetic patients.
Quick Shure New Needleless Syringe
'Ques Shure focuses on medical product innovation, providing a more convenient, safe and comfortable medical experience for patients in China and the world, improving their quality of life. ' Zhang Yuxin, founder and general manager of Kushur, said, 'So, We chose Coase as a partner to produce high quality needle-free syringes to meet the needs of China's growing diabetes population.'
'Costtron has always been a vision to create a wonderful world, which requires us to innovate and find the most cutting-edge solutions, which is impossible.” Wang Xinyu, Sales Director of China Healthcare, Costron Polycarbonate Business Unit, believes that 'Today, the needle-free syringe that everyone sees is proof of our efforts. It can provide patients with a more comfortable and efficient injection experience, which helps patients improve compliance.'
Based on his own experience in needle-free injection, Kushur chose Coxtron's medical grade polycarbonate Makrolon® Rx1805. This product is durable, easy to process, safe and has excellent design flexibility. With superior material performance, Covestro also offers a full range of material solutions for the fast Shure needleless syringe products.
Quick Shure New Needleless Syringe
'Cosmo Model Clone® Rx1805 is mainly used for the production of insulin take-up interface and drug-loaded ampoule in the fast Shure needle-free syringe consumables. 'Chen Suning, head of the Quick Shure Product Center, introduced, 'Materials can meet plastics The precise size, high strength and high toughness of the medicine parts and ampoules ensure that the medicine taking part can pierce the medicine stopper of the insulin bottle safely, and realize the design of the injection cap of the medicine needle and the suction end. A series of rigorous tests have shown that Covestro polycarbonate can achieve multiple indicators of material selection for ampoule: strength, precision molding stability, drug safety and radiation sterilization.
The main advantages of Makrolon® Rx1805 polycarbonate are:
· Oil-resistant chemicals, not easy to crack
· Tolerance to radiation sterilization, ensuring large-scale and efficient production of ampoule
· Biocompatibility, in accordance with ISO10993-1 multiple evaluation requirements
· High impact resistance, not easy to break
· Accurate molding dimensions to maintain stability in different environments
'The future research and development goal of Quick Shure is the integration of injectable drugs and needle-free technology, bringing more convenient pre-filled drug-free needle-free drug delivery systems to the market. With this opportunity, we hope to continue with Covestro. In-depth cooperation, jointly promote the continuous innovation of the technology of needle-free injection. ' Zhang Yuxin added.
If you are attending the 2018 Medtec China Exhibition and the 14th International Medical Device Design and Manufacturing Technology Exhibition held at the Shanghai World Expo Exhibition Hall from September 26th to 28th, please go to the Costron Booth (T101) to learn more. More related applications and material information in the medical industry.
About Covestro:
Covestro is one of the world's largest polymer producers with sales of €14.1 billion in 2017. Its business scope is focused on the manufacture of high-tech polymer materials and innovative solutions for many everyday applications. R&D. The main service areas cover automotive, construction, wood processing and furniture, electrical and electronics, and other areas including sports and leisure, cosmetics, medical and chemical industries. By the end of 2017, Covestro has 30 production sites worldwide. , about 16,200 employees (calculated by full-time employees).
About Quick Shure:
Established in 2007, Beijing Kushur Medical Technology Co., Ltd. is a high-tech enterprise specializing in R&D, production and sales of needle-free drug delivery equipment. The company's production and R&D base is located in Beijing Daxing Economic and Technological Development Zone, with a scale of 100,000. The purification workshop, 10,000-level aseptic laboratory and automated production line for needle-free syringe consumables, the annual output can reach tens of millions of aseptic supplies. At present, the company has developed a variety of models of needle-free injection products, which can be used Insulin injection, auxin injection, interferon, vaccine, anesthesia injection and other fields.
You can download this press release and related images from Covestro News Server at www.covestro.cn. Please indicate the source when using the image.
For more information, please visit www.covestro.cn and http://www.qsjet.com/.
Covestro official WeChat public number: Covestro in China
